A new type of protein translation has been developed that can accurately translate text from English to Chinese.
Read More The protein-based translation technique, called transcriptome-based transcription, uses genetic information from DNA to tell how a protein interacts with the RNA, the genetic material that makes up the protein.
The process is very similar to how a translator reads a text from a computer, except that it is used to translate text into a language that the DNA has not yet been translated to.
The project was funded by a consortium of companies, universities and universities around the world.
It is one of a number of efforts underway to use transcriptome data to create a database of every gene in a human genome.
It would allow researchers to learn about a person’s genome, so that they can better predict their health and develop treatments for diseases like cancer.
The project has been a collaboration between scientists at the University of California, San Francisco, UC Santa Cruz and the University College London.
The researchers were able to successfully translate two different kinds of DNA: DNA from an egg and DNA from a sperm.
The scientists then used that knowledge to create the first transcriptome database.
The transcriptome information allowed them to reconstruct the entire transcriptome, the entire set of genes in the human genome, from a single cell.
This is the first time a gene has been reconstructed from an organism’s transcriptome using only the genetic information in its DNA.
The work also could help to explain why certain genes are more active in certain tissues and diseases.
The transcriptome is not only a tool for researchers to make predictions about the genome, it is also a reference to the gene’s function.
When a cell divides, the DNA of its parent cell is copied into a new cell.
The new cell then divides again.
The gene from that original cell is now part of the genome.
The new cell divides again and repeats this process, creating more cells and more copies of the same gene.
This repeats the process, and so the gene from the original cell can eventually become part of a whole genome.
But in a way, the transcription of the entire genome can also happen in a cell.
That is because each cell’s DNA contains information that tells it what to do, said graduate student Rui Wang.
When the transcription takes place, a gene can be “turned on,” meaning that a protein that binds to DNA at that location can be turned on and turned off.
This is called transcription initiation.
In the cell, these proteins are called transcription factors.
These transcription factors are not the same as the protein that turns on the gene.
But the transcription factors that turn on genes, called transcription activators, are the same, so it is possible to see that the transcription activator that turns off a gene could turn on the same transcription activer that turns it on.
So, by looking at these transcription activations, researchers can predict whether or not a gene is going to be active.
And because transcription activers turn off specific genes, scientists can then use that information to create treatments for disease.
For example, they could determine if a gene that makes people less susceptible to developing certain cancers is going on because the transcriptionactivator that turned it off is also turning off a cancer-causing gene.
This method could help scientists better understand the function of genes.
Because gene expression is the primary function of a gene, the more genes it has, the better off it is.
This is an example of a transcriptome that is being used to study the function and function of cancer genes.
A transcriptome also helps us understand the effects of a drug on a gene.
For example, one way to treat a certain type of cancer is to knock out one of its genes.
When the gene is knocked out, it no longer produces proteins.
But when it is turned back on, it produces another protein that is a target for the cancer drug.
Because it is not known what the cancer-killing activity of the drug is, it has been difficult to find a way to make it work on a specific gene.
In this study, we have shown that by knocking out a specific cancer gene, we can make the drug target that gene.
Now that we know how to make a drug target a gene by turning it on, we know what to look for when we want to target a particular gene.
And this means that we can look at the expression of the genes that are involved in cancer.
These are the results of the work, which is published in the journal PLOS Biology.
This project has important implications for the future of gene therapy.
One of the main concerns is that we need to find ways to treat disease without creating a new disease.
This new method could potentially do that.
So this is one tool that we could use to do this, said Wang.